Innoviva Strategic Opportunities LLC
SEC CIK 1842875 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARMP | Armata Pharmaceuticals, Inc. | Dir, 10% | 10.98M | $22.07M | — | 2 | 2021-10-29 | 2022-02-09 |
Most active insiders at ARMP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kyme Pierre | Chief Business Off | — | — |
| 2 | Birx Deborah | CEO, Dir | — | — |
Innoviva Strategic Opportunities LLC made no open-market trades at ARMP in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-02-11 | 2022-02-09 | ARMP | Armata Pharmaceuticals, Inc. | Innoviva Strategic Opportunities LLC | Dir, 10% | P - Purchase | $5.00 | +3.61M | 10.98M | +49% | +$18.07M |
| I | 2021-11-01 | 2021-10-29 | ARMP | Armata Pharmaceuticals, Inc. | Innoviva Strategic Opportunities LLC | Dir, 10% | P - Purchase | $3.30 | +1.21M | 7.37M | +20% | +$4.00M |
Purchase Sale Sale after option exercise All abbreviations